• Clinical Insights
  • Webinar

Understanding Tardive Dyskinesia: What you need to know

Apr 11th, 2024

Tardive Dyskinesia (TD) – a neurological disorder associated with prolonged use of antipsychotic medications – affects over 600,000 people annually.

Wondering what this means for the people you serve?

Genoa Healthcare recently hosted a webinar to discuss risk factor associated with TD, diagnostic criteria and assessment of TD, and approaches to managing and mitigating the symptoms. The webinar also covered costs and clinical outcomes of treatment options for consumers living with TD.

Watch the recording here:

Let’s talk

Reliable, full-service pharmacy care

Interested in learning more about how Genoa can help support your consumers living with tardive dyskinesia? Contact us today and we’ll be in touch.

"*" indicates required fields

Name*
Does your organization currently partner with Genoa?*
This field is for validation purposes and should be left unchanged.

Recent Posts


  • Blog Post
Partnering with ACT teams to make an even bigger impact

Genoa Healthcare® pharmacist Julie R. has seen firsthand the impact that severe and persistent mental illness can have on a person. For one of her consumers living with schizophrenia, the...

  • Blog Post
  • Webinar
For consumers living with Tardive Dyskinesia, Genoa Healthcare’s Clinical Assistance Program offers personalized support

Tardive Dyskinesia – a neurological disorder linked to prolonged use of antipsychotic medications – impacts over 600,000 individuals each year. Did you know that 50% of consumers taking TD medication...

  • Blog Post
A foundation to build on: 3 ways an engaged pharmacy partner helps you deliver whole-person health

A recent survey found that nearly 60% of behavioral health, primary care and complex care providers reported that their organization currently offered or had plans to begin offering integrated care...

  • Clinical Insights
  • Webinar
Understanding Tardive Dyskinesia: What you need to know

Tardive Dyskinesia (TD) – a neurological disorder associated with prolonged use of antipsychotic medications – affects over 600,000 people annually. Wondering what this means for the people you serve? Genoa...